Erythropoietins: a common mechanism of action.
D000740:Anemia / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001803:Blood Transfusion; D049109:Cell Proliferation / Q000187:drug effects; D000068256:Darbepoetin alfa; D004912:Erythrocytes / Q000378:metabolism; D015672:Erythroid Precursor Cells / Q000378:metabolism*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D006207:Half-Life; D006397:Hematinics / Q000378:metabolism* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D017467:Receptors, Erythropoietin / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*
D006397:Hematinics; D017467:Receptors, Erythropoietin; D004921:Erythropoietin; D000068256:Darbepoetin alfa